Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Trevor D Thompson

Showing results (61-70 of 79) with videos related to

Pageof 8
Sort By:
Journal of Thrombosis and Thrombolysis|April 26, 2003
The determinants of activated partial thromboplastin time, relation of activated partial thromboplastin time to clinical outcomes, and optimal dosing regimens for heparin treated patients with acute coronary syndromes: a review of GUSTO-IIbMichael S Lee, Andreas U Wali, Venu Menon, et al.
Journal of Cancer Research & Therapy|June 20, 2017
<i>KRAS</i> testing and first-line treatment among patients diagnosed with metastatic colorectal cancer using population data from ten National Program of Cancer Registries in the United StatesAdriana Rico, Lori A Pollack, Trevor D Thompson, et al.
JAMA Oncology|September 12, 2024
Cervical Cancer Incidence in the US-Affiliated Pacific IslandsSameer V Gopalani, Jin Qin, Janos Baksa, et al.
Cancer|November 5, 2008
Examining the association between socioeconomic status and potential human papillomavirus-associated cancersVicki B Benard, Christopher J Johnson, Trevor D Thompson, et al.
Pediatric Blood & Cancer|October 23, 2023
A comprehensive analysis of neuroblastoma incidence, survival, and racial and ethnic disparities from 2001 to 2019Kevin Campbell, David A Siegel, Puja J Umaretiya, et al.
Oral Oncology|March 31, 2019
Human papillomavirus DNA detection, p16<sup>INK4a</sup>, and oral cavity cancer in a U.S. populationBrenda Y Hernandez, Charles F Lynch, Owen T M Chan, et al.
JNCI Cancer Spectrum|January 1, 2019
Population-Based Assessment of HPV Genotype-Specific Cervical Cancer Survival: CDC Cancer Registry Sentinel Surveillance SystemBenjamin D Hallowell, Mona Saraiya, Trevor D Thompson, et al.
Urology|June 27, 2024
Scrotal Cancer Incidence Rates and Trends-United States, 1999-2020Jacqueline M Mix, Sameer V Gopalani, Maureen Miller, et al.
Cancer Epidemiology|January 10, 2020
Breast and colorectal cancer recurrence and progression captured by five U.S. population-based registries: Findings from National Program of Cancer Registries patient-centered outcome researchTrevor D Thompson, Lori A Pollack, Christopher J Johnson, et al.
The American Journal of Gastroenterology|October 11, 2017
A Comparison of Fecal Immunochemical and High-Sensitivity Guaiac Tests for Colorectal Cancer ScreeningJean A Shapiro, Janet K Bobo, Timothy R Church, et al.
Pageof 8

Showing results (61-70 of 79) with videos related to

Sort By:
Pageof 8
Journal of Thrombosis and Thrombolysis|April 26, 2003
The determinants of activated partial thromboplastin time, relation of activated partial thromboplastin time to clinical outcomes, and optimal dosing regimens for heparin treated patients with acute coronary syndromes: a review of GUSTO-IIbMichael S Lee, Andreas U Wali, Venu Menon, et al.
Journal of Cancer Research & Therapy|June 20, 2017
<i>KRAS</i> testing and first-line treatment among patients diagnosed with metastatic colorectal cancer using population data from ten National Program of Cancer Registries in the United StatesAdriana Rico, Lori A Pollack, Trevor D Thompson, et al.
JAMA Oncology|September 12, 2024
Cervical Cancer Incidence in the US-Affiliated Pacific IslandsSameer V Gopalani, Jin Qin, Janos Baksa, et al.
Cancer|November 5, 2008
Examining the association between socioeconomic status and potential human papillomavirus-associated cancersVicki B Benard, Christopher J Johnson, Trevor D Thompson, et al.
Pediatric Blood & Cancer|October 23, 2023
A comprehensive analysis of neuroblastoma incidence, survival, and racial and ethnic disparities from 2001 to 2019Kevin Campbell, David A Siegel, Puja J Umaretiya, et al.
Oral Oncology|March 31, 2019
Human papillomavirus DNA detection, p16<sup>INK4a</sup>, and oral cavity cancer in a U.S. populationBrenda Y Hernandez, Charles F Lynch, Owen T M Chan, et al.
JNCI Cancer Spectrum|January 1, 2019
Population-Based Assessment of HPV Genotype-Specific Cervical Cancer Survival: CDC Cancer Registry Sentinel Surveillance SystemBenjamin D Hallowell, Mona Saraiya, Trevor D Thompson, et al.
Urology|June 27, 2024
Scrotal Cancer Incidence Rates and Trends-United States, 1999-2020Jacqueline M Mix, Sameer V Gopalani, Maureen Miller, et al.
Cancer Epidemiology|January 10, 2020
Breast and colorectal cancer recurrence and progression captured by five U.S. population-based registries: Findings from National Program of Cancer Registries patient-centered outcome researchTrevor D Thompson, Lori A Pollack, Christopher J Johnson, et al.
The American Journal of Gastroenterology|October 11, 2017
A Comparison of Fecal Immunochemical and High-Sensitivity Guaiac Tests for Colorectal Cancer ScreeningJean A Shapiro, Janet K Bobo, Timothy R Church, et al.
Pageof 8